Actively Recruiting
Chronic Lung Allograft Dysfunction MRI Study
Led by Sean Fain · Updated on 2025-03-27
100
Participants Needed
1
Research Sites
180 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This studies purpose is to confirm the efficacy and efficiency of using OE-MRI and MRI with hyperpolarized gas techniques and Iodinated contrast CT scan, this will enhance understanding of CLAD pathophysiology. Moreover, this project is foundational to performing additional studies to establish if novel MRI imaging can serve as an objective confirmatory diagnostic tool for CLAD in post-transplant patients.
CONDITIONS
Official Title
Chronic Lung Allograft Dysfunction MRI Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ages 18 to 80 years
- English speaking
- Willingness and ability to provide informed consent
- Non-smoker
- At least 6 months post bilateral lung transplant
- Stable spirometry with FEV1 greater than 90% of baseline and forced mid-expiratory flow (FEF) (25-75) greater than 75% of baseline for CLAD-free patients
- Total Lung Capacity (TLC) greater than 90% of baseline for CLAD-free patients
- Post-transplant chest X-ray without significant abnormalities for CLAD-free patients
- No active lung infection or allograft rejection for CLAD-free patients
- FEV1 less than 80% of baseline for early CLAD patients
- Follow-up of 6 months or decline in lung function (20% decrease in FEV1 without infection or acute rejection) for early CLAD patients
You will not qualify if you...
- Oxygen saturation drops below 90% during normal breathing (without mechanical failure)
- Unilateral diaphragm paralysis
- Evidence of acute illness on the day of study
- Evidence of restrictive lung disease
- Dependence on supplemental oxygen
- History of cardiac disease
- Pregnancy (self-declared)
- Lactating women
- Presence of metal objects in the body
- Known contraindication to MRI
- Systolic blood pressure less than 100 mmHg or greater than 200 mmHg
- Diastolic blood pressure less than 60 mmHg or greater than 100 mmHg
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Iowa
Iowa City, Iowa, United States, 52242
Actively Recruiting
Research Team
S
Sean Fain, Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here